Lipocine (LPCN) Earnings Analysis
Lipocine (LPCN) has no confirmed upcoming earnings date. Last quarter (2026-05-07) it missed with EPS -0.54 USD vs -0.51 USD est (-5.9%). It has beaten estimates in 3/5 recent quarters (60%). Trailing P/E -1.14.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does LPCN next report earnings?
No confirmed upcoming earnings date is currently scheduled for LPCN. This page updates as the calendar is published.
LPCN earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-07 | -0.54 USD | -0.51 USD | -5.9% | Miss |
| 2026-03-09 | -0.34 USD | -0.6 USD | +43.3% | Beat |
| 2025-11-06 | -0.59 USD | -0.56 USD | -5.4% | Miss |
| 2025-05-08 | -0.35 USD | -0.35 USD | 0% | Beat |
| 2025-03-13 | 0.33 USD | -0.4 USD | +182.5% | Beat |
Beat rate: 3/5 (60%) over reported quarters with consensus data.
LPCN valuation and analyst view
| Trailing P/E | -1.14 |
|---|---|
| Trailing EPS | -1.68279 USD |
| Price / book | 0.66 |
| Dividend yield | 0.00% |
| Market cap | 0.01B |
| Analyst consensus | Buy (7 buy / 2 hold / 0 sell) |
| Avg price target | 10.5 USD |
Related research pages
Frequently asked questions
When is Lipocine (LPCN)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for LPCN. This page updates as the calendar is published.
Did LPCN beat earnings last quarter?
In its 2026-05-07 report, LPCN posted EPS of -0.54 USD versus a -0.51 USD estimate — a miss of 5.9%.
What is LPCN's earnings track record?
Over the last 5 reported quarters with consensus data, LPCN beat estimates 3 times (60%).
What is LPCN's current P/E ratio and EPS?
LPCN trades at a trailing P/E of -1.14 on trailing EPS of -1.6827852832965415 USD.
What do analysts rate LPCN?
Analyst consensus is "Buy" across 9 ratings (0 strong buy, 7 buy, 2 hold, 0 sell, 0 strong sell). Average 12-month price target: 10.5 USD.